Recombinant Anti-DHODH antibody [EPR11814] - BSA and Azide free (ab238968)


  • Product name

    Anti-DHODH antibody [EPR11814] - BSA and Azide free
    See all DHODH primary antibodies
  • Description

    Rabbit monoclonal [EPR11814] to DHODH - BSA and Azide free
  • Host species

  • Tested applications

    Suitable for: WBmore details
    Unsuitable for: Flow Cyt,ICC/IF,IHC-P or IP
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Recombinant fragment within Human DHODH. The exact sequence is proprietary.
    Database link: Q02127

  • Positive control

    • WB: Human fetal heart tissue lysate. SK-BR-3, MCF7, HepG2 and Jurkat cell lysates.
  • General notes

    Ab238968 is the carrier-free version of ab174288. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.


    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

    ab238968 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.



Our Abpromise guarantee covers the use of ab238968 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent concentration. Predicted molecular weight: 43 kDa.
  • Application notes
    Is unsuitable for Flow Cyt,ICC/IF,IHC-P or IP.
  • Target

    • Function

      Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
    • Pathway

      Pyrimidine metabolism; UMP biosynthesis via de novo pathway; orotate from (S)-dihydroorotate (quinone route): step 1/1.
    • Involvement in disease

      Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:263750]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.
    • Sequence similarities

      Belongs to the dihydroorotate dehydrogenase family. Type 2 subfamily.
    • Post-translational

      The uncleaved transit peptide is required for mitochondrial targeting and proper membrane integration.
    • Cellular localization

      Mitochondrion inner membrane.
    • Information by UniProt
    • Database links

    • Alternative names

      • DHOdehase antibody
      • Dhodh antibody
      • Dihydroorotate dehydrogenase (quinone) antibody
      • Dihydroorotate dehydrogenase antibody
      • Dihydroorotate dehydrogenase mitochondrial antibody
      • Dihydroorotate oxidase antibody
      • Human complement of yeast URA1 antibody
      • mitochondrial antibody
      • POADS antibody
      • PYRD_HUMAN antibody
      • URA1 antibody
      see all


    • All lanes : Anti-DHODH antibody [EPR11814] (ab174288) at 1/1000 dilution

      Lane 1 : SK-BR-3 (Human mammary gland adenocarcinoma cell line) cell lysate
      Lane 2 : Human fetal heart tissue lysate
      Lane 3 : MCF7 (Human breast adenocarcinoma cell line) cell lysate
      Lane 4 : HepG2 (Human liver hepatocellular carcinoma cell line) cell lysate
      Lane 5 : Jurkat (Human T cell leukemia cell line from peripheral blood) cell lysate

      Lysates/proteins at 10 µg per lane.

      Predicted band size: 43 kDa

      Note: ab174288 is diluted in 1% BSA.

      This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, tissue culture supernatant and sodium azide (ab174288).


    ab238968 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab238968.
    Please use the links above to contact us or submit feedback about this product.

    For licensing inquiries, please contact

    Sign up